Related Experiment Videos
Lipoprotein composition in hypothyroidism
Insights
Hypothyroidism significantly impacts lipid profiles, causing high cholesterol and triglycerides. Replacement therapy effectively lowers cholesterol but not triglycerides, suggesting VLDL conversion abnormalities in hypothyroidism.
Area of Science:
- Endocrinology
- Lipid Metabolism
Background:
- Hypothyroidism is associated with dyslipidemia.
- Prevalence of hypercholesterolemia and hypertriglyceridemia in hypothyroid patients is high.
Purpose of the Study:
- To assess the lipid status in hypothyroid patients.
- To evaluate the effect of thyroid hormone replacement therapy on lipid profiles.
Main Methods:
- Lipid status assessment in 16 hypothyroid patients.
- Analysis before and during replacement therapy.
Main Results:
- Over 60% of patients exhibited hypercholesterolemia and hypertriglyceridemia.
- Significant reduction in plasma cholesterol observed during therapy.
- Plasma triglyceride levels did not significantly change.
- High cholesterol:triglyceride ratio in VLDL normalized during treatment.
Conclusions:
- Thyroid hormone replacement therapy improves hypercholesterolemia in hypothyroidism.
- Potential abnormality in Very Low-Density Lipoprotein (VLDL) to Low-Density Lipoprotein (LDL) conversion in hypothyroidism.
- Further research needed to elucidate VLDL metabolism in hypothyroid states.
Abstract:
Sixteen patients with hypothyroidism have had their lipid status assessed before and during replacement therapy. More than 60% had hypercholesterolaemia and more than 60% had hypertriglyceridaemia. Significant reductions in plasma cholesterol, but not in plasma triglyceride, were seen during replacement therapy. A high cholesterol: triglyceride ratio was observed in VLDL and this relationship tended back to normal during treatment. This raises the possibility that in hypothyroidism, as in Type III hyperlipoproteinaemia, an abnormality in VLDL conversion to LDL is present.